Skipping meals at certain times of the day for a few months can slightly lower blood sugar levels in people with metabolic syndrome.
Scientific Claim
Intermittent fasting reduces fasting blood glucose by 0.15 mmol/L in adults with metabolic syndrome over interventions averaging 3 months, indicating modest improvement in short-term glucose control.
Original Statement
“The fasting blood glucose level decreased by 0.15 mmol/L (95% CIs: −0.23; −0.06) after the IF diet.”
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design supports claim
Appropriate Language Strength
definitive
Can make definitive causal claims
Assessment Explanation
The study design is a systematic review of RCTs (Level 1a evidence), which permits causal language. The effect size is small but statistically significant and reported with confidence intervals.
Evidence from Studies
Supporting (1)
Unknown Title
This study found that people with metabolic syndrome who tried intermittent fasting lowered their fasting blood sugar by exactly 0.15 mmol/L, which is a small but real improvement—just like the claim says.